Valbiotis reports positive Cardio-Liver results; liver product Sept. 23
Valbiotis says its randomized, placebo-controlled Cardio-Liver study of Steadrive was positive and plans to launch ValbiotisPRO Foie in France on Sept. 23.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Valbiotis reports positive Cardio-Liver study results; Sept. 23 launch
Valbiotis says it has positive results from its Cardio-Liver clinical study and plans to commercialize ValbiotisPRO® Foie on September 23.